(FILES) In this file photo taken on May 20, 2020 pills of Hydroxychloroquine sit on a tray at Rock Canyon Pharmacy in Provo, Utah.
Photo by AFP
MSD won U.K. authorization for its new antiviral coronavirus treatment, the first such approval for an oral medicine to treat adults suffering mild-to-moderate cases of COVID-19, the Medicines and Healthcare products Regulatory Agency (MHRA) announced Thursday.
